FLVCR2 and posterior cortical atrophy: identified DOCK9, PTGFR, NREP, SCARNA22, FLVCR2, CLASP1, IK2F3, and USP13 as potential biomarkers predicting the progression of PCa, especially between stage II and subsequent stages (123).